NASDAQ · Biotechnology

REGN (REGN) Stock

$823.82 +3.10% NASDAQ: REGN Healthcare

Valuation

MetricValue
Price$823.82
Market Cap$84.87B
P/E Ratio19.46
P/B Ratio2.66
P/S Ratio5.40
EPS (TTM)$41.48
52-Week High$847.00
52-Week Low$541.00
Dividend Yield0.46%

Financials & Margins

MetricValue
ROE13.81%
ROA10.37%
ROCE10.97%
Gross Margin24.95%
Operating Margin24.95%
Net Margin27.86%
Debt/Equity0.06
Current Ratio4.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.1B$12.2B$13.1B$14.2B$14.3B
Operating Profit$8.9B$5.4B$4.3B$4.0B$3.6B
Net Profit$8.1B$4.3B$4.0B$4.4B$4.5B
EPS$71.97$38.22$34.77$38.34$41.48
Op Margin55.7%44.2%33.1%28.1%24.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$25.4B$29.2B$33.1B$37.8B$40.6B
Total Liabilities$6.7B$6.6B$7.1B$8.4B$9.3B
Cash$2.9B$3.1B$2.7B$2.5B$3.1B
Borrowings$2.7B$2.7B$2.7B$2.7B$2.7B

Latest News

Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's MT Newswires · Jul 15, 2026 1 Large-Cap Stock with Exciting Potential and 2 We Turn Down StockStory · Jul 14, 2026 Own Regeneron For Biotech Growth? Incyte Is Making Its Case. Trefis · Jul 13, 2026 Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2 Insider Monkey · Jul 13, 2026 Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855 MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$7.1B$5.0B$4.6B$4.4B$5.0B
Investing Cash Flow$-5.9B$-4.4B$-4.1B$-3.2B$-1.5B
Financing Cash Flow$-3.7B$-3.0B$-2.9B$-3.7B$-4.0B
Net Cash Flow$691.0M$221.0M$-382.0M$-249.0M$635.0M
Free Cash Flow$6.5B$4.4B$3.7B$3.7B$4.1B

Valuation & Return Ratios

MetricValue
PEG Ratio62.48
EV / EBITDA14.52
FCF Yield4.20%
Quick Ratio2.78
Interest Coverage71.66
Return 1Y37.72%
Return 3Y-3.43%
Return 5Y14.71%

Ownership

Insiders Held2.03%
Institutions Held92.24%
Institutions Float Held94.15%
Institutional HolderSharesReport Date
Blackrock Inc.8,947,7352026-03-31
Vanguard Capital Management LLC6,654,9132026-03-31
State Street Corporation4,664,4782026-03-31
Dodge & Cox Inc.4,458,2382026-03-31
JPMORGAN CHASE & CO4,311,8062026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALNY $246.11 +2.25% 73.95 $32.93B 0.00%
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
CI $283.06 +2.53% 11.58 $74.80B 2.22%
COR $330.97 +2.28% 23.93 $64.39B 0.74%
ELV $403.04 +2.67% 17.89 $87.41B 1.71%

About REGN

REGN is led by CEO Leonard S. Schleifer, employs 15,158 people, headquartered in Tarrytown, US, publicly traded since 1991.

REGN stock trades at $823.82 with a market capitalization of $84.87B. The stock is valued at a price-to-earnings (P/E) ratio of 19.46, price-to-book of 2.66, price-to-sales of 5.40. Over the past 52 weeks the stock has ranged between $541.00 and $847.00, and currently trades 2.7% below its 52-week high. It pays a dividend yielding 0.46%.

On profitability, REGN generates a return on equity (ROE) of 13.81%, above the typical market average, return on capital employed of 10.97%, an operating margin of 24.95%, a net profit margin of 27.86%.

In its most recent fiscal year, REGN reported annual revenue of $14.3B, net profit of $4.5B, revenue has compounded at 11.0% a year over the last five years, profit at 5.1% a year.

The balance sheet shows a debt-to-equity ratio of 0.06 — a conservative balance sheet with little leverage risk, a current ratio of 4.13, total assets of $40.6B, $3.1B in cash and equivalents.

REGN has a beta of 0.24 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides